Skip to search formSkip to main contentSkip to account menu

GSK 2118436

Known as: GSK-2118436A, GSK2118436, GSK-2118436 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Combining immunotherapy with targeted therapy blocking oncogenic BRAF may result in improved treatments for advanced melanoma. In… 
2013
2013
Background: Conventional therapeutic agents are largely unsatisfactory into the treatment of malignant melanoma. Recently, an… 
2013
2013
A phase I study was conducted to assess the metabolism and excretion of [C]dabrafenib (GSK2118436; N-{3-[5-(2-amino-4-pyrimidinyl…